TRANSCRIPTIONAL, EPIGENETIC, AND SIGNAL EVENTS IN ANTIFOLATE THERAPEUTICSAlexandra C. RacanelliVCU Scholars Compass (Virginia Commonwealth University)January 1, 200910.25772/c741-2h49Cited by 0SaveCiteExport RISWatch citationsRelated PapersAnti-complement C5 therapy with eculizumab in three cases of critical COVID-19|Clinical Immunology|2020|128